Genmab wins Scrip's Biotech Company of the Year award
The award recognizes Genmab's accomplishments during 2006 and 2007 including the work to bring new products closer to their first markets, raise capital, enter significant licensing agreements, maintain strong management, address unmet medical needs through development of new technology UniBody® and to transform Genmab from an early stage to a more mature world leading biotechnology company.
"Receiving the Scrip Award is a testament to the skill and efficiency of all Genmab employees who have worked hard to make our business grow. We are delighted to have won and are honored to receive this year's Scrip Award for Biotech Company of the Year," said Lisa N. Drakeman, Ph.D., Chief Executive Officer at Genmab.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.